Zurück zu Ihrem Suchergebnis

Beschreibung

A cyanopyrrolidine compound that acts as a potent DPP IV inhibitor (IC50 = 3, 5, 8, and 8 nM in inhibiting rat, human, monkey, and canine DDP IV, respectively). Oral administration of K579 in rats in vivo has been shown to reduce blood DPP IV activity and augment GLP-1 and insulin response after glucose intake and significantly reduce plasma glucose concentration., Please note: 328.4 is the anhydrous molecular weight, please refer to the vial label for the lot-specific hydration and molecular weight.